The Discounted Cash Flow (DCF) valuation of Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS) is 3.28 CNY. With the latest stock price at 4.44 CNY, the upside of Zhejiang CONBA Pharmaceutical Co Ltd based on DCF is -26.0%.
Based on the latest price of 4.44 CNY and our DCF valuation, Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS) is a sell. selling 600572.SS stocks now will result in a potential gain of 26.0%.
| Range | Selected | |
| WACC / Discount Rate | 8.1% - 11.3% | 9.7% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 2.48 - 5.09 | 3.28 |
| Upside | -44.1% - 14.6% | -26.0% |